5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts

BACKGROUND: All-trans retinoic acid (ATRA)-based treatment of acute promyelocytic leukemia (APL) is the most successful pharmacological treatment of acute myeloid leukemia (AML). Recent development of inhibitors of mutated isocitrate dehydrogenase and dihydroorotate dehydrogenase (DHODH) has revived...

Descripción completa

Detalles Bibliográficos
Autores principales: Dembitz, Vilma, Lalic, Hrvoje, Kodvanj, Ivan, Tomic, Barbara, Batinic, Josip, Dubravcic, Klara, Batinic, Drago, Bedalov, Antonio, Visnjic, Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657321/
https://www.ncbi.nlm.nih.gov/pubmed/33176741
http://dx.doi.org/10.1186/s12885-020-07533-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657321/
https://www.ncbi.nlm.nih.gov/pubmed/33176741
http://dx.doi.org/10.1186/s12885-020-07533-6

Ejemplares similares